At a Glance
| 2C-T-2 | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 10–20 mg | 100–225 µg |
| Total Duration | 3–6 hrs | 3.3–7 hrs |
| Routes | insufflatedoral | oral |
2C-T-2, a Psychedelic, and 1cP-AL-LAD, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 42 documented effects in common, with 9 effects unique to 2C-T-2 and 30 unique to 1cP-AL-LAD. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 2C-T-2 | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 10–20 mg | 100–225 µg |
| Total Duration | 3–6 hrs | 3.3–7 hrs |
| Routes | insufflatedoral | oral |
| Effects | 51 documented | 72 documented |
| Interaction | Low Risk & Synergy | |
| Level | 2C-T-2 | 1cP-AL-LAD |
|---|---|---|
| Threshold | 3 mg | 20 µg |
| Light | 5–10 mg | 50–100 µg |
| Common | 10–20 mg | 100–225 µg |
| Strong | 20–30 mg | 225–350 µg |
| Heavy | 30 mg | 350 µg |
| Level | Dose |
|---|---|
| Threshold | 1 mg |
| Light | 5–10 mg |
| Common | 10–20 mg |
| Strong | 20–25 mg |
| Heavy | 25 mg |
2C-T-2
1cP-AL-LAD
Cross-tolerance exists; effects compound
No dangerous interactions recorded.
No dangerous interactions recorded.